These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28478399)

  • 1. A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis.
    Deng D; Zhang P; Guo Y; Lim TO
    Ann Rheum Dis; 2017 Aug; 76(8):1436-1439. PubMed ID: 28478399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
    Ginzler EM; Wofsy D; Isenberg D; Gordon C; Lisk L; Dooley MA;
    Arthritis Rheum; 2010 Jan; 62(1):211-21. PubMed ID: 20039429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study.
    Zhu Y; Huang C; Zheng L; Li Q; Ge J; Geng S; Zhai M; Chen X; Yuan H; Li Y; Jia W; Sun K; Li Y; Ye T; Zhao Z; Liu H; Liu Z; Jiang H
    Stem Cell Res Ther; 2024 Apr; 15(1):122. PubMed ID: 38679727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.
    Gu J; Huang L; Zhang C; Wang Y; Zhang R; Tu Z; Wang H; Zhou X; Xiao Z; Liu Z; Hu X; Ke Z; Wang D; Liu L
    Stem Cell Res Ther; 2020 Feb; 11(1):43. PubMed ID: 32014055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages.
    Guo F; Pan Q; Chen T; Liao S; Li S; Li A; Chen S; Chen J; Xiao Z; Su H; Yang L; Yang C; Liu HF; Pan Q
    Stem Cell Res Ther; 2023 Aug; 14(1):211. PubMed ID: 37605271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical cord-derived mesenchymal stem cell sheets transplanted subcutaneously enhance cell retention and survival more than dissociated stem cell injections.
    Nakao M; Matsui M; Kim K; Nishiyama N; Grainger DW; Okano T; Kanazawa H; Nagase K
    Stem Cell Res Ther; 2023 Dec; 14(1):352. PubMed ID: 38072920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China.
    Huang L; Zou J; Zhang Y; Gu J; Wu J; Zhang C
    BMJ Open; 2024 Mar; 14(3):e075138. PubMed ID: 38490657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human umbilical cord mesenchymal stem cell transfusion in immune non-responders with AIDS: a multicenter randomized controlled trial.
    Wang L; Zhang Z; Xu R; Wang X; Shu Z; Chen X; Wang S; Liu J; Li Y; Wang L; Zhang M; Yang W; Wang Y; Huang H; Tu B; Liang Z; Li L; Li J; Hou Y; Shi M; Wang FS
    Signal Transduct Target Ther; 2021 Jun; 6(1):217. PubMed ID: 34103473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human umbilical cord mesenchymal stem cell transplantation for the treatment of acute-on-chronic liver failure: protocol for a multicentre random double-blind placebo-controlled trial.
    Wang Y; Li M; Yang T; Xie Y; Wang FS; Hu J; Shi M
    BMJ Open; 2024 Jun; 14(6):e084237. PubMed ID: 38925694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethyloxallyl Glycine Preconditioning Promotes the Anti-inflammatory and Anti-fibrotic Effects of Human Umbilical Cord Mesenchymal Stem Cells on Kidney Damage in Systemic Lupus Erythematosus Related to TGF-β/Smad Signaling Pathway.
    Ning A; Xiao N; Yu X; Wang H; Guan C; Guo C; Dong Y; Ma X; Xia H
    Inflammation; 2024 Jul; ():. PubMed ID: 39044003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Safety and Efficacy of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Patients With Heart Failure and Myocardial Infarction: A Meta-Analysis of Clinical Trials.
    Abouzid MR; Ali K; Kamel I; Esteghamati S; Saleh A; Ghanim M
    Cureus; 2023 Nov; 15(11):e49645. PubMed ID: 38033439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial.
    Jayne D; Rovin B; Mysler E; Furie R; Houssiau F; Trasieva T; Knagenhjelm J; Schwetje E; Tang W; Tummala R; Lindholm C
    Lupus Sci Med; 2023 Aug; 10(2):. PubMed ID: 37607780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial.
    Saxena A; Ginzler EM; Gibson K; Satirapoj B; Santillán AEZ; Levchenko O; Navarra S; Atsumi T; Yasuda S; Chavez-Perez NN; Arriens C; Parikh SV; Caster DJ; Birardi V; Randhawa S; Lisk L; Huizinga RB; Teng YKO
    Arthritis Rheumatol; 2024 Jan; 76(1):59-67. PubMed ID: 37466424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti-CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
    Jayne DR; Steffgen J; Romero-Diaz J; Bajema I; Boumpas DT; Noppakun K; Amano H; Gomez HM; Satirapoj B; Avihingsanon Y; Chawanasuntorapoj R; Madero M; Naumnik B; Recto R; Fagan N; Revollo I; Wu J; Visvanathan S; Furie R
    Arthritis Rheumatol; 2023 Nov; 75(11):1983-1993. PubMed ID: 37192040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purified umbilical cord derived mesenchymal stem cell treatment in a case of systemic lupus erythematosus.
    Phillips CD; Wongsaisri P; Htut T; Grossman T
    Clin Transl Med; 2017 Dec; 6(1):31. PubMed ID: 28782090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
    Jørgensen KK; Olsen IC; Goll GL; Lorentzen M; Bolstad N; Haavardsholm EA; Lundin KEA; Mørk C; Jahnsen J; Kvien TK;
    Lancet; 2017 Jun; 389(10086):2304-2316. PubMed ID: 28502609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord mesenchymal stem cells for the treatment of autoimmune diseases: beware of cell-to-cell contact.
    Alunno A; Bistoni O; Montanucci P; Basta G; Calafiore R; Gerli R
    Ann Rheum Dis; 2018 Mar; 77(3):e14. PubMed ID: 28611081
    [No Abstract]   [Full Text] [Related]  

  • 19. Lupus nephritis: Cholesterol accumulation in DCs promotes autoimmunity.
    Carney EF
    Nat Rev Nephrol; 2017 Jul; 13(7):383. PubMed ID: 28529341
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis.
    Barbado J; Tabera S; Sánchez A; García-Sancho J
    Lupus; 2018 Nov; 27(13):2161-2165. PubMed ID: 30290717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.